Cargando…
Prevalence and effect on survival of pre-treatment sarcopenia in patients with hematological malignancies: a meta-analysis
BACKGROUND & AIMS: Evidence regarding the prevalence of pre-treatment sarcopenia and its impact on survival in patients with hematological malignancies (HM) varies across studies. We conducted a systematic review and meta-analysis to summarize this discrepancy. METHODS: PubMed, Embase and Cochra...
Autores principales: | Xiong, Jianzhu, Chen, Kangkang, Huang, Wen, Huang, Mingang, Cao, Feiyan, Wang, Yiwen, Chen, Qifeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587577/ https://www.ncbi.nlm.nih.gov/pubmed/37869092 http://dx.doi.org/10.3389/fonc.2023.1249353 |
Ejemplares similares
-
Impact of BCR-ABL1 Transcript Type on Outcome in Chronic Myeloid Leukemia Patients Treated With Tyrosine Kinase Inhibitors: A Pairwise and Bayesian Network Meta-Analysis
por: Chen, Kangkang, et al.
Publicado: (2022) -
Ferroptosis in hematological malignant tumors
por: Liu, Yong, et al.
Publicado: (2023) -
Arginase: Mechanisms and Clinical Application in Hematologic Malignancy
por: Du, Zefan, et al.
Publicado: (2022) -
Sarcopenia Is Associated With Hematologic Toxicity During Chemoradiotherapy in Patients With Anal Carcinoma
por: Martin, Daniel, et al.
Publicado: (2020) -
Association between sarcopenia and survival in patients with gynecologic cancer: A systematic review and meta-analysis
por: Lin, Wen-Li, et al.
Publicado: (2023)